Skip to main content
. 2021 Jun 2;8:658747. doi: 10.3389/fmed.2021.658747

Figure 4.

Figure 4

Cost-effectiveness plane of different treatment options. QALYs, quality-adjusted life years; ABE, abemaciclib; RIB, ribociclib; PAL, palbociclib; FUL, fulvestrant.